FY 2021 CDMRP Policy on the Inclusion of Women and Minorities in Clinical Research

On December 15, 2020, notification was sent to the research community of the recently implemented Fiscal Year 2021 Congressionally Directed Medical Research Programs (CDMRP) policy on the Inclusion of Women and Minorities in Clinical Research and associated changes to application requirements.

In 2019 the Department of Defense (DoD) was directed by the U.S. Senate Appropriations Subcommittee on Defense to develop a plan to ensure the appropriate representation of women and minorities in its extramural research.

The Policy states that women and individuals from minority groups be included in all CDMRP-funded clinical research studies, unless there is a clear, justifiable rationale that it is inappropriate with respect to the health of the subjects or the purpose of the research. Applicants will be required to include a strategy for the inclusion of women and minorities in all clinical research (e.g. studies involving human subjects or identifiable human biospecimens or datasets) and submit an anticipated enrollment table(s) with the proposed enrollment distributed on the basis of sex/gender, race, and ethnicity at the time of proposal submission. Additional post-award reporting requirements will be specified in the terms and conditions of applicable awards.

For the complete policy, FAQs, and suggested inclusion enrollment report format, please see the “Resources and Reference Material” section under the Funding Opportunities and Forms tab after logging onto the electronic Biomedical Research Application Portal (eBRAP) at https://eBRAP.org. Please also refer to the detailed descriptions of funding opportunities, evaluation criteria, and submission requirements, which can be found in each Program Announcement.